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The advent of thoracic endovascular aortic repair
is associated with broadened treatment eligibility
and decreased overall mortality in traumatic
thoracic aortic injury
Michael S. Hong, MD, Robert J. Feezor, MD, W. Anthony Lee, MD, and
Peter R. Nelson, MD, MS, Gainesville, Fla
Background: Aortic injury is the second leading cause of death in trauma. Thoracic endovascular aortic repair (TEVAR)
has recently been applied to traumatic thoracic aortic injuries (TTAIs) as a minimally invasive alternative to open surgery.
We sought to determine the impact of TEVAR on national trends in the management of TTAI.
Methods: We queried the Nationwide Inpatient Sample from the years 2001 to 2007 to select patients diagnosed with
TTAI (International Classification of Disease-9 code 901.0). Patients were evaluated based on open surgical repair,
TEVAR, or nonoperative management, before and after widespread adoption of TEVAR (2001-2005 and 2006-2007).
Outcomes of interest were inpatient mortality, length of stay (LOS), and major complications.
Results: An estimated 1180 annual admissions occurred for TTAI in the United States. Comparing the two time periods,
there was an increase in TEVAR (P< .001) with a simultaneous decrease in open repair (P< .001) in 2006 to 2007. The
overall number of interventions also increased (P < .001). Overall mortality decreased (25.0% vs 19.0%;P < .001),
corresponding to improved survival in the nonoperative group (28.0% vs 23.2%; P < .001). There was no improvement
in open repair mortality rates between the two time periods. Comparing intervention types, the TEVAR group had a
higher percentage of patients with brain injury (26.1% vs 20.6%; P  .008), lung injury (25.0% vs 17.7%; P < .001), and
hemothorax (32.5% vs 21.7%; P < .001) than the open surgery group. There were no differences in the number of
intra-abdominal injuries or major orthopedic fractures. The open surgery group had more respiratory complications
(43.9% vs 54.2%; P< .001), whereas TEVAR had a higher stroke rate (1.9% vs 0.7%; P .021). There were no differences
in paraplegia or renal failure. Overall in-hospital mortality was 23.2% (nonoperative group 26.7%, open repair 12.4%, and
TEVAR 10.6%). Mortality between open repair and TEVAR groups were not significantly different. LOS was shorter
among the TEVAR group vs open (15.7 vs 22.9 days; P < .001).
Conclusion: TEVAR has replaced open repair as the primary operative treatment for TTAI and has extended operative
treatment to those patients not previously considered candidates for repair. Increased utilization of TEVAR is associated
with improved overall mortality. There is no difference in mortality between TEVAR and open repair groups in our
study, which likely reflects the multisystem nature of injury and greater preoperative risk in the TEVAR group. (J Vasc
Surg 2011;53:36-43.)Traumatic thoracic aortic injury (TTAI) is a highly
lethal injury that occurs predominately after motor vehicle
collisions.1,2 The majority of those with TTAI die before
reaching the hospital, and for those admitted, the patients
receiving open surgical repair have traditionally faced high
morbidity and mortality.
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36Thoracic endovascular aortic repair (TEVAR) has re-
cently been introduced as aminimally invasive alternative to
open repair. The first thoracic stent graft that the Food &
Drug Administration approved for use in the United States
became commercially available in 2005. There has been
enthusiastic reception to thoracic endografting, and several
clinical trials of new devices are currently underway.
However, due to the relative infrequency of hospital
admissions with TTAI, most studies to date have been
single-institution retrospective reports. Questions remain
concerning nationwide outcomes of contemporary open
surgical repair, the increasing use of TEVAR, and how the
emergence of TEVAR has affected the TTAI population.
We used the Nationwide Inpatient Sample (NIS) in order
to investigate our hypothesis that TEVAR improves sur-
vival of patients with TTAI on a national scale.
METHODS
The NIS is an administrative database of inpatient
admissions collected from participating states that com-
prises approximately 20% of all admissions in the United
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of admissions in the country. Weights are applied per
admission based on the known number of discharges of a
given hospital, as reported by the American Hospital Asso-
ciation, so that the sampled data accurately reflect the
national population.3
Since the NIS maintains de-identified data, this study
was approved as exempt by the institutional review board of
the University of Florida College of Medicine.
Using the NIS database from the years 2001 to 2007,
we selected patients based on the diagnosis of injury to the
thoracic aorta, using code 901.0 from the International
Classification of Diseases, 9th Revision (ICD-9). Three
main treatment groups were identified based on the type of
management. Specifically, we evaluated for the type of surgical
repair using ICD-9 procedure codes for open thoracic vessel
replacement (ICD-9 procedure code 38.45) and endovascu-
lar graft implantation to the thoracic aorta (ICD-9 procedure
code 39.73). Patients who had neither procedure code were
considered to have beenmanagednonoperativelywith respect
to their thoracic aortic injury.
An a priori list of clinically relevant comorbidities and
complications was selected. The patient demographics of
interest were age, coronary artery disease, diabetes mellitus,
obesity, chronic obstructive pulmonary disease, and hyper-
tension. Concomitant injuries of the brain, heart, lungs,
intra-abdominal organs, and major bony structures were
recorded. Brain injury included all patients with a loss of
consciousness lasting for greater than 24 hours, brain lac-
eration or contusion, or intracranial hemorrhage. Heart
and lung injury included both contusion and laceration.
Abdominal injury was defined as injury to the gastrointes-
tinal tract, pancreas, liver, spleen, kidney, or bladder. Major
orthopedic fracture was defined as any fracture of the spine,
pelvis, or femur. The presence of hemothorax was evalu-
ated as a general estimate of the severity of aortic injury and
the need for blood transfusion was also noted. Complica-
tions included acute renal failure, stroke, paraplegia, and
pulmonary complications. Pulmonary complications were
specifically defined as pulmonary edema, pulmonary col-
lapse, pneumonia, pulmonary insufficiency after trauma,
transfusion-related acute lung injury, and acute respiratory
failure (Table I). The primary outcome in comparing the
treatment groups was in-hospital mortality. Secondary out-
comes included stroke, paraplegia, acute renal failure, pul-
monary complications, length of stay (LOS), discharge to
home, and associated total hospital charges. Notably, ad-
missions that had paraplegia without spinal fractures have
distinct ICD-9 codes than those with associated spinal
fractures, and the latter group was not counted for the
purpose of evaluating procedure-related paraplegia. We
included only ischemic stroke in our analysis in order to
avoid overlap of procedure-related stroke from hemor-
rhagic stroke due to trauma.
In evaluating the effect of endovascular repair on the
overall cohort of patients with TTAI, we performed sub-
group analysis comparing two time periods, before and
after widespread use of TEVAR for TTAI. Although theFood & Drug Administration approval came in 2005,
widespread adoption of this practice was not seen until
2006. Therefore, we chose time period 1 (T1) as the years
2001 to 2005, and time period 2 (T2) as 2006 to 2007.
All statistics incorporated discharge-level weights pro-
vided in the NIS database. We used the independent sam-
ple t test to compare numerical means, and Pearson’s 2 to
compare categorical variables from 2  2 contingency
tables at an alpha of 0.05. Individual predictors of mortality
were identified with logistic regression. Statistically signifi-
cant variables (P  .05) were then incorporated into a
multivariable analysis to identify independently predictive
factors, and adjusted odds ratios with 95% confidence in-
tervals were calculated. Adjusted odds ratios for interven-
tion type excluded variables describing postprocedural
complications. All statistical analysis was performed with
SPSS 17 for Windows (SPSS Inc, Chicago, Ill).
RESULTS
Overall cohort. Our patient selection resulted in
8269 admissions over the 7-year time period. There was an
average of 1181  159 annual admissions with a diagnosis
of injury to the thoracic aorta. Eleven percent of these
admissions were originally transfers from another hospital.
The average age was 43  20 years. Overall, men com-
prised 72% of admissions, whereas 28% were women. In-
hospital mortality for all patients with TTAI was 23.2%,
with a mean length of stay of 17  20 days.
As expected, TTAI was frequently accompanied by injury
to one or more other body systems. Brain injury was found in
23.9%, intra-abdominal injury in 43.3%, and major orthope-
dic fractures in 49.1%. Taken together, 71.5% had concomi-
Table I. ICD-9 codes screened
ICD-9 codes for comorbidities, concomitant injuries, and
complications
Obesity 278.x
Diabetes mellitus 250.x
Hypertension 401.x
Coronary artery disease 414, 414.0x, 414.8, 414.9
Congestive heart failure 428.x
Chronic obstructive
pulmonary disease
492.x, 496.x
Hemothorax 860.2-860.5
Packed red blood cell
transfusion
990.4
Brain injury 850.3-850.5, 850.9, 851-854.x
Heart injury 861.0-861.1x
Lung injury 861.2-861.3x
Abdominal injury 863-869.x
Major orthopedic injury 805.x, 806.x, 808.x, 820.x, 821.x
Pulmonary complications 481, 482, 518.0, 518.4, 581.5,
518.7, 518.81-2
Acute renal failure 584.x, 586.x, 997.5
Paraplegia (lower
extremity)
344.1
Ischemic stroke 434.91, 997.02
ICD-9, International Classification of Diseases, 9th Revision.tant injury to at least one of these three systems.
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sion or laceration was diagnosed in only 4.6% of patients,
which likely reflects the preselected group that survives
until hospitalization.
Treatment modalities. There were only 14 TEVARs
coded for TTAI in 2005 in the United States. It is impor-
tant to note, however, that the ICD-9 procedure code for
TEVAR was not created until late 2005. Subsequent years
saw widespread adoption of this treatment modality, with
279  27 TEVAR for trauma per year during the years
2006 to 2007. In contrast, there were 215  62 open
thoracic aorta repairs from 2001 to 2005, which was sig-
nificantly fewer in 2006 to 2007 at 138  36 (P  .001).
The number of interventions, which includes both endo-
vascular and open repair, increased by 90%, from 218 61
in the years 2001 to 2005 to 417  53 in 2006 to 2007
(P  .001). TEVAR comprised 67% of all repairs of the
thoracic aorta in trauma in the latter time period (Fig 1).
Surgical management comparison. A detailed com-
parison between open repair and TEVAR is shown in Table
II. Patients receiving TEVAR generally were older, had
more severe injuries (hemothorax and blood transfusion),
and more concomitant injuries compared to the open re-
pair group. In particular, the TEVAR group had more
patients with brain injury and lung injury, which may
be due to the challenge of systemic anticoagulation and
single-lung ventilation, respectively. A larger proportion of
those receiving open repair were women compared to
TEVAR, likely reflecting the smaller female aorta being
unsuitable for the larger available thoracic endografts orig-
inally designed for degenerative rather than traumatic pa-
thologies.
Direct comparison of open repair and TEVAR is lim-
ited by the fact that more than 70% of patients have
concomitant potentially life-threatening injuries. We found
that unadjusted mortality in the open repair and TEVAR
groups were similar (P  .273).
TEVARhad fewer pulmonary complications, and the rate
of stroke was statistically higher compared to open repair.
Paraplegia rates were low for both open repair and TEVAR,
Fig 1. Proportion of patients receiving intervention by year.
TEVAR, Thoracic endovascular aortic repair.with both being less than 2%. LOS was shorter with TEVAR,although both groups exhibited a wide range. Slightly more
patients treated with TEVAR were discharged home (54%)
compared to open repair (49%; P .048).
Predictors of mortality. Significant predictors of mor-
tality are listed in Table III. On multivariable analysis, age,
brain injury, abdominal injury, hemothorax, acute renal fail-
ure, packed red blood cell transfusion, and stroke were inde-
pendently associated with increasedmortality. Notably, heart,
lung, and orthopedic injury, when evaluated alone, did not
predict increased mortality. However, the number of injuries
(a composite of brain, abdominal, heart, lung, orthopedic)
was positively associated with death (Table IV).
Time period comparison. There was no significant
change in the number of hospital admissions for TTAI
between T1 and T2. We saw a significant improvement in
mortality for the entire cohort when comparing T1 and T2.
Subset analysis demonstrated a pronounced improvement
in the nonoperative group and also ruled out any contribu-
tion from the open repair group (Fig 2). This improvement
in mortality of the overall cohort, and the nonoperative
group in particular, was seen despite a higher prevalence of
brain, abdominal, and lung injury in T2 (Table V). The
mortality improvement persisted after controlling for co-
morbidities and injuries (Table IV).
DISCUSSION
Summary of findings. Administrative databases, such
as the NIS, are useful in understanding national trends,
particularly when the disease or treatment occurs relatively
infrequently, as is the case in TTAI. With the NIS, we were
able to obtain estimates of incidence of hospitalizations for
TTAI and also observe national trends for TEVAR in a
sample group that closely reflects all providers in theUnited
States, including urban or rural, private or academic, and
low or high volume. In addition, by using administrative
data, we were able to avoid publication bias that can result
from single-institution reports.
Our results show approximately 1180 annual hospital
admissions of patients with TTAI, of which 11% are trans-
fers from another hospital. Despite the availability of seat-
belts and airbags, greater than 70% of these patients will
have concomitant injury to the brain, intra-abdominal or-
gans, or major bones, which present challenges in their
overall care. As a result, overall mortality remains high,
although there was a significant improvement in 2006 to
2007 compared to 2001 to 2005. This improvement in
overall mortality occurred concomitant with an increase in
use of TEVAR, which not only replaced open repair, but
also expanded therapeutic options for those who would
have previously been treated nonoperatively.
There are several reasons why an increase in TEVAR
and fewer nonoperatively managed patients may increase
survival in the overall group. The most intuitive reason is
that TEVAR is being used to treat patients with severe
TTAI who were, for one reason or another, precluded from
open repair. Second, TEVAR has several advantages over
open repair, namely being able to avoid systemic anticoag-
ulation, single-lung ventilation, or lateral decubitus posi-
VAR,
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those with brain injury, pulmonary injury, or major ortho-
pedic injury, respectively. Indeed, the TEVAR group had a
significantly shorter hospital LOS than the open repair
Table II. Demographics comparison of treatment groups
Comparison o
Demographics Nonoperative
Age 44.2  21.2
Female 28.3%
Obesity 1.3%
DM 3.4%
HTN 14.1%
CAD 6.6%
CHF 4.2%
COPD 2.7%
Hemothorax 26.8%
pRBC transfusion 21.6%
Concomitant injury
Brain injury 24.4%
Abdominal injury 42.5%
Orthopedic injury 47.7%
Heart injury 4.6%
Lung injury 19.6%
Avg. No. of injuries (0-5) 1.39
Complications
Pulmonary complications 40.6%
Acute renal failure 6.8%
Paraplegia 0.8%
Stroke 1.4%
Primary outcomes
Mortality 26.7%
Length of stay 15.8  20.0
Discharge to home 50%
Total hospital charges $163,253
CAD, Coronary artery disease; CHF, congestive heart failure; COPD, chro
pRBC, packed red blood cells; TEVAR, thoracic endovascular aortic repair
aValue compares open repair and TEVAR.
Table III. Predictors of overall mortality from multivariab
Predictors of mortality Adjusted od
Intervention (nonoperative, TEVAR, open) 0.602
Age 1.019
Diabetes 0.555
Obesity 0.581
Coronary artery disease 1.476
Congestive heart failure 1.031
COPD 0.458
Hypertension 0.378
Hemothorax 1.354
Brain injury 1.594
Abdominal injury 1.259
Orthopedic injury 0.982
Lung injury 0.867
Pulmonary complications 0.436
Paraplegia 0.265
Acute renal failure 2.903
Blood transfusion 2.207
Ischemic stroke 6.202
CI, Confidence interval; COPD, chronic obstructive pulmonary disease; TEgroup. A third explanation is that those with less severeTTAI, but with other concomitant injuries, may benefit
fromTEVAR so that competingmanagement priorities can
be reduced. For instance, those with mild TTAI may only
need strict blood pressure control, however, this is subop-
tment groups
Open repair TEVAR P valuea
38.6  17.4 41.8  17.6  .001
29.8% 19.5%  .001
1.1% 1.7% .201
1.7% 3.6% .021
9.0% 10.4% .381
3.6% 3.5% .951
1.3% 0.8% .396
3.1% 4.5% .101
21.7% 32.5%  .001
22.1% 28.0% .004
20.6% 26.1% .008
44.6% 47.9% .085
53.3% 54.4% .665
4.1% 5.4% .179
17.7% 25.0%  .001
1.40 1.60  .001
54.2% 43.9%  .001
9.3% 8.7% .718
0.8% 1.8% .072
0.7% 1.9% .021
12.4% 10.6% .273
22.9  20.8 15.7  14.2  .001
49% 54% .048
$207,692 $192,759 .056
bstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension;
alysis
io 95% CI lower 95% CI upper P value
0.55 0.659  .001
1.016 1.022  .001
0.383 0.806 .002
0.323 1.044 .069
1.181 1.845 .001
0.769 1.384 .836
0.306 0.686  .001
0.308 0.463  .001
1.197 1.531  .001
1.405 1.809  .001
1.121 1.414  .001
0.876 1.102 .761
0.751 1 .050
0.386 0.492  .001
0.106 0.666 .005
2.385 3.532  .001
1.952 2.497  .001
4.154 9.26  .001
thoracic endovascular aneurysm repair.f trea
nic o
.le an
ds rattimal for cerebral perfusion in the setting of severe brain
jury, a
ransfu
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concomitant injuries, TEVAR may improve outcomes, not
strictly by preventing aortic rupture but by optimizing
overall management. The higher number of patients with
brain injury in the TEVAR group supports this view.
Looking at the operatively managed subset, there was
no unadjusted mortality difference between the open repair
and TEVAR group, which likely reflects the high frequency
of other potentially life-threatening injuries in both groups
and a higher preoperative risk in the TEVAR group in
particular. The TEVAR group not only had more severe
aortic injuries (hemothorax or blood transfusion), but on
average, had more concomitant injuries as well. Further-
more, thoracic endografting had additional technical chal-
lenges, including being a relatively new procedure during
the time period studied, relatively inexperienced providers,
use of evolving early-generation device technology, and
off-label use for a generally younger trauma population.
The thoracic endografting data in our study reflect that of a
rapidly developing treatment paradigm, the outcomes of
which may continue to improve in the near future. TEVAR
had a similar mortality during the study time period despite
these disadvantages. There was a trend toward improved
Table IV. Predictors of mortality
Predictors of mortality Adjusted odds ratio
Open repair (vs TEVAR)a 1.333
Overall T1 (vs T2)a 1.494
Nonoperative T1 (vs T2)a 1.361
1-2 concomitant injuries (vs 0)b 1.246
3-5 concomitant injuries (vs 0)b 1.409
CAD, Coronary artery disease; CI, confidence interval; COPD, chronic obs
thoracic endovascular aneurysm repair.
aAfter controlling for age, DM, CAD, COPD, HTN, hemothorax, brain in
bAfter controlling for age, DM, CAD, COPD, HTN, hemothorax, blood t
Fig 2. Comparison of mortality by treatment group and time
period.
* Overall group: P  .001.
** Nonoperative group: P  .001.survival in TEVAR after adjusting for these comorbiditiesand concomitant injuries, however, this analysis did not
reach statistical significance (P  .092).
LOS was shorter after TEVAR, although both open
repair and TEVAR groups exhibited a wide range, reflect-
ing the heterogeneity of severity in traumatic injury. Pa-
tients were slightly more likely to be discharged home with
or without a home health aide; however, approximately half
in either group were either transferred or discharged to a
subacute setting. Total charges were similar between
TEVAR and open repair, likely reflecting the influence of
concomitant injuries and resultant similar intensive care,
and the cost of thoracic endografts.
Paraplegia rates were low and similar in both treatment
groups. Renal failure was similar and low, yet was strongly
associatedwith increasedmortality. The strongest predictor of
mortality was ischemic stroke, which occurred in 1.9% of the
TEVAR group and 0.7% of the open repair group.
Comparison with previous reports. Our annual in-
cidence rates closely agree with reports by Parmley et al1
and Fabian et al,4 who estimated that 10% to 15% of an
estimated 8000 patients with traumatic aortic injuries sur-
vive until hospitalization. Mortality in the open repair
group was better than expected based on several meta-
analyses and multicenter studies that generally quote a
mortality of 15% to 20% compared to 12.4%, as seen in our
study.5,6 The reason for lower-than-expected open repair
mortality is unclear but not entirely unprecedented. There
are several contemporary studies focusing solely on open
repair outcomes that report hospital mortalities between
5% to 12%.7,8 A multicenter prospective study of trauma
centers by Fabian et al4 in 1997 reported TTAI open repair
mortality of 14%.Had open repair been closer to the 15% to
20% often cited, we anticipate that the advantage of
TEVAR would have been even more pronounced.
Neurological complications of paraplegia and stroke
reported here are both low compared to traditional rates.
The rates reported here likely involve some underreporting,
and caution should be taken to interpret complication
rates as absolute values in an administrative database. In
addition, we used a conservative approach to assigning
complications, with more exclusionary than inclusionary
assumptions. For example, paraplegia coded as part of a
spinal fracture was not included as a complication, and only
ischemic stroke was counted as a complication in order to
95% CI lower 95% CI upper P value
0.954 1.863 .092
1.324 1.686  .001
1.187 1.560  .001
1.080 1.437 .003
1.175 1.689  .001
e pulmonary disease; DM, diabetes mellitus; HTN, hypertension; TEVAR,
bdominal injury, blood transfusion.
sion.tructivdistinguish hemorrhagic stroke resulting from traumatic
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our conservative assumptions, both should apply to all
subsets equally, and, therefore, differences should be appar-
ent. Findings from the National Trauma Data Bank study
similarly reported low neurological complication rates with-
out major differences between open and endovascular repair
groups.9 The low neurological complication rates, however,
do reflect the general trend of improved neurologic outcomes
in the past decade, as seen in the results of amulticenter trial by
Demetriades et al10 who found significantly lower rates of
paraplegia during 2005 to 2007 compared to 1994 to 1996.
When compared with results from a large meta-analysis by
Tang et al,5 our reported open repair stroke rate is lower.
However, in that meta-analysis, the overall open repair results
were skewed by two outlying values: 9 of 11 studies reported
stroke rates well below 1%, and the remaining two reported
rates of 12% and 17%.11,12
Limitations. A limitation of an ICD-9-based admin-
istrative database is the lack of certain clinically relevant
information, such as the severity of injury. Generally speak-
ing, an ICD-9 code provides information about the pres-
ence of a disease but sparse information about its severity.
For example, although we used the presence of hemotho-
Table V. Comparison of mortality, concomitant injuries,
Time peri
All patients T1 (2001-200
Mortality 25.0%
Avg. No. of injuries
(0-5)
1.36
Brain injury 22.9%
Abdominal injury 41.4%
Orthopedic injury 48.7%
Heart injury 4.6%
Lung injury 18.6%
Hemothorax 26.4%
pRBC transfusion 20.2%
Nonoperative
Mortality 28.0%
Avg. No. of injuries
(0-5)
1.35
Brain injury 23.4%
Abdominal injury 41.1%
Orthopedic injury 47.6%
Heart injury 4.6%
Lung injury 18.7%
Hemothorax 27.0%
pRBC transfusion 19.9%
Open repair
Mortality 12.1%
Avg. No. of injuries
(0-5)
1.39
Brain injury 20.6%
Abdominal injury 43.1%
Orthopedic injury 53.0%
Heart injury 4.8%
Lung injury 18.2%
Hemothorax 23.6%
pRBC transfusion 21.4%
pRBC, Packed red blood cells.rax as a marker of severity in TTAI, we have no directinformation about the actual severity of the aortic injury, or
the amount of blood found in the chest. This limitation
importantly precludes us from assigning the most com-
monly used predictor of mortality in the trauma popula-
tion, namely the Injury Severity Score. It is important to
note, however, that there are reports in the literature of
considerable effort and success to adjust for risk based on
ICD-9 data by counting the number of concomitant inju-
ries.13,14 This is the method used in our study.
Another limitation of an ICD-9-based administrative
database is that clinically relevant information is dependent
on the availability and accuracy of proper diagnostic and
procedural codes. It is important to note that in this study,
TEVAR was not assigned an ICD-9 procedure code until
October 2005, and, therefore, any TEVAR performed
prior to the updated ICD-9 cannot be identified. We have
attempted to address this limitation in several ways. First,
we examined our own institution’s database in order to
estimate the number of TEVARs performed for TTAI at an
academic hospital with an aggressive endovascular practice
in years prior to 2005. As mentioned in the report by
Feezor et al,15 we performed a total of 22 TEVARs for
TTAI, none of which were done between 2001 and 2004,
everity between time periods
parison
T2 (2006-2007) P value
19.1%  .001
1.50  .001
26.3% .001
47.5%  .001
49.9% .317
4.5% .834
22.1%  .001
26.2% .839
26.4%  .001
23.2%  .001
1.49  .001
27.2% .002
46.6%  .001
47.9% .816
4.6% .933
22.3% .002
26.0% .395
26.1%  .001
13.8% .452
1.43 .618
20.4% .916
50.7% .022
54.6% .597
1.5% .013
15.6% .303
14.2% .001
24.8% .250and s
od com
5)3 in 2005, and the rest in 2006 to 2008. Second, we
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coded to the nearest equivalent procedure, namely endo-
vascular aneurysm repair (EVAR). We found 30 instances
from 2004 to 2006 in which a patient was coded to have
received an EVAR with a diagnostic code of TTAI but not
traumatic abdominal aortic injury. These cases accounted
for less than 5% of the endovascular therapy group and less
than 1% of the overall group of patients with TTAI. Alter-
natively, some may have elected to code TEVAR as open
repair, prior to 2005, which we would not be able to readily
distinguish. The significant and abrupt decrease in open
repair in 2006 to 2007 compared to 2001 to 2005 is
evidence that coding to the nearest equivalent procedure,
whether EVAR or open repair, is relatively infrequent. Our
main findings of increased TEVAR use over time, and the
improved overall mortality, are unlikely to be altered by
miscoding. However, the possibility of coding TEVAR as
open repair may have introduced an artifact that reduced
open repair mortality and prevented statistically significant
difference between the two types of repair in our study.
A limitation specific to the NIS is that, while approxi-
mately 20% of US hospitals are sampled annually, it is not
the same hospitals sampled each year. The year-to-year
differences in the sampled hospitals can introduce variabil-
ity in the results with regard to hospital characteristics, such
as low- or high-volume centers, trauma level designation,
and providers who are experienced in endovascular therapy.
Finally, we cannot assign any cause and effect to our
findings. Although there is dramatic improvement in overall
mortality in just 2 years, factors other thanTEVARcould have
contributed to the differences. Dramatic improvements in
medical management and intensive care are unlikely to have
occurred in just 2 years, but it cannot be ruled out.
CONCLUSION
Traumatic thoracic aortic injury remains highly lethal.
The cause of death in this population is multifactorial given
the nature of the injury, and we did not find significant
differences in open repair group vs the TEVAR group. In
addition, TEVAR is being applied to an older patient group
with more concomitant injuries, which may reduce the
advantage of a minimally invasive procedure.
TEVAR has replaced open repair as the primary surgical
treatment of choice in TTAI, and TEVAR seems to have
extended operative treatment to those patients not previ-
ously considered candidates for repair.
Taken together, the data strongly demonstrates that
TEVAR is being used as a less invasive option for patients with
greater preoperative risk, including those whowere previously
precluded from intervention, resulting in improved overall
outcomes. The widespread application of TEVAR is associ-
ated with a decrease in the overall mortality rate from TTAI.
Further studies are required to establish long-term trends and
outcomes with this new treatment modality.AUTHOR CONTRIBUTIONS
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Dr Mark A. Farber (Chapel Hill, NC ) Dr Hong and his
fellow authors from the University of Florida should be com-
mended for their excellent presentation, and a well-written and
prompt submission of their manuscript.
As you have heard, their report quite nicely details their
hypothesis and analysis of patients diagnosed and treated with
blunt thoracic aortic injuries in the United States during the time
period from 2001 thru 2007.
It is important to note that their findings are based on a review
of the National Inpatient Sampling database for these years and the
assumption that thoracic endovascular aneurysm repair (TEVAR)
was rarely used prior to 2005 for treating patients with this type of
injury.
While I agree that the data support the conclusions that
TEVAR has replaced open repair in patients with blunt aortic
injury (BAI) during the past 5 years, I am not yet convinced that
the data collected support the additional conclusions of TEVAR vs
open repair.
The authors openly admit that there are inherent problems
analyzing data of this sort. For instance, the injury severity score
and degree of blunt injury was not recorded and, therefore, their
impact on outcome cannot be determined. These factors have been
shown in several published studies to provide significant influence
in this respect.
Do not, however, mistake my belief that TEVAR provides
significant benefits in this patient population and that before long,
additional data will support its routine use for patients with signif-
icant BAI.
The basis for my criticism instead is founded on numerous
inconsistencies in the data that call into question its validity beyond
observational trends and patient demographics. In an effort to sort
out some of these issues, I would like to ask the authors a few
questions.
By your report, there are approximately 1200 patient admis-
sions per year, and of those, 450 have undergone either surgical or
endovascular treatment. This implies that an astounding 60% or
more of the patients are being managed nonoperatively. While I
realize that universally, trauma teams around the nation have
migrated to nonoperative management of most injuries, I doubt
this is the case with blunt thoracic aortic injuries (BTAIs). This
number is more than three times the percentage of patients man-
aged nonoperatively in our practice. Can you explain why there is
a high percentage of cases managed nonoperatively?
Second, do you have accurate records concerning the disposi-
tion of the patients at discharge? Is it not possible that those
patients that are discharged with nonoperative management from
smaller hospitals without advanced aortic specialists are actually the
same ones being transferred to regional medical centers like yours
and mine and undergo endovascular repair? If that is in fact the
case, then the results for nonoperative and endovascular therapy
would be significantly altered and the total number of injuries
reduced.
I also take issue with your assumption of TEVAR for BAI prior
to 2006. While you found 14 reported cases of TEVAR for BTAI
in 2005 and hypothesize that some 30 additional cases may have
been coded as infrarenal endovascular aneurysm repair (EVAR)
instead. Your conclusion was that this would have a minor impact
on the results.
Let’s analyze the data in a little different fashion. If I add
together your three reported cases in 2005, the five we performed
at University of North Carolina and those performed by DrRosenthal’s group, then over 33% of the cases in the United States
were conducted at these three institutions. I find this hard to
believe and wonder if physicians were not coding endovascular
repair of BTAI as an open thoracic repair Current Procedure
Terminology code during this early time period. This minor
change would have a profound impact on all the results reported
and cannot be dismissed or accounted for in your analysis. I would
appreciate your thoughts on this possibility.
While registries and databases like the Nationwide Inpatient
Sample are important in obtaining demographic data and changes
in practice patterns over time, it is my opinion and that of others
that drawing conclusions about patient outcomes and treatment
modalities is extremely difficult because of the lack of detail and
inconsistencies in the data and the inability to verify the validity of
the data.
In closing, I am reminded of something my wise mentor, Dr
Keagy, always said, “You do not need to do chi-square analysis on
common sense.”
I would like to thank the society for the privilege of discussing
this paper.
DrHong.Thank you, Dr Farber, for your comments. I would
like to address the first question on the high rates of nonoperative
repair. There has been an increase in the liberal use of computed
tomography scans as a screening tool in trauma patients. The
American Association for the Surgery of Trauma 2 trial showed
that most traumatic thoracic aortic injuries in this decade were
diagnosed with computed tomography scans, which may pick up
more incidental aortic injuries. These incidental diagnoses would
increase the number of patients managed nonoperatively.
Second, as you mentioned, the Nationwide Inpatient Sample
is an inpatient database, and it tracks data by each hospital admis-
sion, not by patient. Therefore, patients who are transferred to
another hospital may be counted twice. These transfers may con-
tribute to the increased nonoperative rate. Our analysis has shown
that approximately 10% of admissions are transfers from a different
hospital. So whereas some of the high nonoperative rate can be
explained by an artifact of an inpatient database, we feel that the
majority of the high nonoperative rate reflects true changes con-
sisting of better diagnosis and evolving management strategies.
Finally, I will address the miscoding of TEVAR. As men-
tioned, the procedure code for TEVAR was introduced in late
2005. We know from prior reports from several academic centers
that TEVAR for traumatic thoracic aortic injuries was being per-
formed before the code for this procedure was available, but these
cases would not be found if we only searched for the TEVAR-
specific procedure code. In order to address this limitation, we
looked at abdominal endovascular repair in those with thoracic
aortic injuries but no documented abdominal aortic injuries, with
the idea that TEVAR might be coded with the closest available
procedure code. Only about 1% of the thoracic aortic injury
population was coded in that manner. We found that our main
findings were not significantly changed when we assumed these
EVARs were actually TEVARs.
However, if these TEVARs were instead coded as open re-
pairs, it would be very difficult to distinguish these cases from true
open repairs in our analysis. Overlap of these two groups would
pose an additional challenge in the already difficult task of finding
differences in outcome between endovascular and open repair in
the setting of a patient with multiple injuries. I agree with Dr
Farber that conclusions regarding differences in outcome between
open and endovascular repair should be made with caution.
